Society ❯ Women's Health

Reproductive Rights

Abortion Access Abortion Healthcare Access Access to Healthcare Abortion Pills Medication Abortion Emergency Medical Treatment Abortion Issues Health Care Access Abortion Medication Pro-Life vs. Pro-Choice Debate Funding Issues Abortion Legislation Telehealth Services Partnerships Political Discourse State Laws Medication Risks Pregnancy Termination Abortion Laws Maternal Care Access Access to Care In Vitro Fertilization Health Disparities Legal Challenges Public Health Public Perception Fertility Medical Negligence

Judge Pauses Louisiana Challenge, Leaves Mail-Order Abortion Pill Policy Intact

The court stay gives the FDA time to finish a promised safety review of mifepristone.

Report Says Complications Rose After FDA Allowed Mail-Order Abortion Pills

Planned Parenthood Mar Monte Launches Botox and Other Paid Services to Offset Medicaid Cuts

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

ACLU Sues FDA to Obtain Records on Mifepristone Review